1887

Abstract

Lymphoproliferation against foot-and-mouth disease (FMD) virus was examined using peripheral blood mononuclear cells from vaccinated cattle. Ten weeks after revaccination the optimum conditions for proliferation were obtained with 1 μg/ml of purified virus after 5 to 6 days in culture. This contrasted with the response at 20 months post-revaccination, when the response required less antigen and showed a peak response after 3 to 4 days in culture. Proliferation was specific for FMD virus, but was cross-reactive between serotypically distinct strains of the virus. The proliferative response to isolated virus proteins (VP) involved all three major capsid proteins (VP1, −2 and −3), although the proliferation of lymphocytes from heterotypically vaccinated cattle was due to VP3. Furthermore, the response induced by purified virus, chemically fixed virus and subunit virus particles was indistinguishable and thus it is likely that processing was required for the induction of proliferation. Together these data strongly suggest that FMD virus-induced lymphoproliferation is T cell-mediated and that VP3 may contain dominant, cross-reactive sequences.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-71-2-309
1990-02-01
2021-10-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/71/2/JV0710020309.html?itemId=/content/journal/jgv/10.1099/0022-1317-71-2-309&mimeType=html&fmt=ahah

References

  1. Abou-Zeid C., Filley E., Steele J., Rook G. A. W. 1987; A simple new method for using antigens separated by polycrylamide gel electrophoresis to stimulate lymphocytes in vitroafter converting bands cut from Western blots into antigen-bearing particles. Journal of Immunological Methods 98:5–10
    [Google Scholar]
  2. Ahl R. 1968; Undersuchungen zur Thermoinaktivierung des Maul- und Klauenseuche-Virus. Archiv für die gesamte Virusforschung 24:361–386
    [Google Scholar]
  3. Asso J., Aynaud J.-M., Portalier R. 1966; Sensibilité á l’acidite des souches de virus aphteux non pathogènes pour le pore. Compte Rendu de l’Academie des Sciences 262:585–588
    [Google Scholar]
  4. Bachrach H. L., Moore D. M., Mckercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Journal of Immunology 115:1636–1641
    [Google Scholar]
  5. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the nucleotide sequence. Nature; London: 29830–33
    [Google Scholar]
  6. Blackman M. A., Kappler J. W., Marrack P. 1988; T-cell specificity and repertoire. Immunological Reviews 101:5–19
    [Google Scholar]
  7. Borras-Cuesta F., Fedon Y., Petit-Camurdan A. 1987; Engineering of immunogenic peptides by co-linear synthesis of determinants recognised by B and T cells. European Journal of Immunology 17:1213–1215
    [Google Scholar]
  8. Borras-Cuesta F., Fedon Y., Petit-Camurdan A. 1988; Enhancement of peptide immunogenicity by linear polymerisation. European Journal of Immunology 18:199–202
    [Google Scholar]
  9. Collen T., Mccullough K. C., Doel T. R. 1984; Induction of antibody to foot-and-mouth disease virus in presensitised mouse spleen cultures. Journal of Virology 52:650–655
    [Google Scholar]
  10. Corradin G., Etlinger H. M., Chiller J. M. 1977; Lymphocyte specificity to protein antigens. I. Characterisation of the antigen- induced in vitroT cell-dependent proliferative response with lymph node cells from primed mice. Journal of Immunology 119:1048–1053
    [Google Scholar]
  11. Cox J. H., Ivanyi J., Young D. B., Lamb J. R., Syred A. D., Francis M. J. 1988; Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. European Journal of Immunology 18:2015–2019
    [Google Scholar]
  12. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
    [Google Scholar]
  13. Doel T. R., Baccarini P. J. 1981; Thermal stability of foot-and- mouth disease virus. Archives of Virology 70:21–32
    [Google Scholar]
  14. Doel T. R., Fletton B. W., Staple R. S. 1982; Further developments in the quantification of small RNA viruses by UV photometry of sucrose density gradients. Developments in Biological Standardization 50:209–219
    [Google Scholar]
  15. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
    [Google Scholar]
  16. Francis M. J., Fry C. M., Rowlands D. J., Bittle J. L., Houghten R. A., Lerner R. A., Brown F. 1987a; Immune response to uncoupled peptides of foot-and-mouth disease virus. Immunology 61:1–6
    [Google Scholar]
  17. Francis M. J., Hastings G. Z., Syred A. D., McGinn B., Brown F., Rowlands D. J. 1987b; Non-responsiveness to a foot-and- mouth disease virus peptide overcome by addition to foreign helper T-cell determinants. Nature; London: 300168–170
    [Google Scholar]
  18. Good M. F., Maloy W. L., Lunde M. N., Margalit H., Cornette I. L., Smith G. L., Moss B., Miller L. H., Berzofsky J. A. 1987; Construction of synthetic immunogen: Use of new T-helper epitope on malaria circumsporozoite protein. Science 235:1059–1062
    [Google Scholar]
  19. Haresnape J. M., McCahon D. 1983; Four independent antigenic determinants on the capsid polypeptides of aphthovirus. Journal of General Virology 64:2345–2355
    [Google Scholar]
  20. King A. M. Q., Newman J. W. I. 1980; Temperature sensitive mutants of foot-and-mouth disease virus with altered structural polypeptides. I. Identification by electrofocussing. Journal of Virology 34:59–60
    [Google Scholar]
  21. King A. M. Q., Underwood B. O., McCahon D., Newman J. W. I., Brown F. 1981; Biochemical identification of viruses causing the 1981 outbreaks of foot-and-mouth disease in the UK. Nature; London: 293479–480
    [Google Scholar]
  22. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. J., Mckercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214:1125–1129
    [Google Scholar]
  23. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature; London: 227680–685
    [Google Scholar]
  24. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouzé P. 1973; Neutralisation en culture cellulaire infectieux du virus de la fievre aphteuse par des sérums provenant de pores immunisés à l’aide d’une protéine virale purifiée. Compte Rendu de l’Academie des Sciences 276D:3399–3401
    [Google Scholar]
  25. Lee K. C., Singh B., Barton M. A., Procyshyn A., Wong M. 1979; A simple reliable system for studying antigen-specific murine T cell proliferation. Journal of Immunological Methods 25:159–170
    [Google Scholar]
  26. Livingstone A. M., Fathman C. G. 1987; The structure of T-cell epitopes. Annual Reviews of Immunology 5:477–501
    [Google Scholar]
  27. Margalit H., Spouge J. L., Cornette J. L., Cease K. B., DeLisi C., Berzofsky J. A. 1987; Prediction of immunodominant helper T cell antigenic sites from the primary sequence. Journal of Immunology 138:2213–2229
    [Google Scholar]
  28. Mckercher P. D., Graves J. H., Cunliffe H., Callis J. J., Fernándes M. V., Martins I. A., Fernandez A. A., Gomes I., Augé De Mello P., Palacios C. A. 1975; Foot-and-mouth disease vaccines. I. Comparison of vaccines prepared from virus inactivated with formalin and adsorbed on aluminium hydroxide gel with saponin and virus inactivated with acetylethyleneimine and emulsified with incomplete Freund’s adjuvant. Bolletin Centro Panamericano Fiebre Aftosa 19- 20:9–16
    [Google Scholar]
  29. Murdin A. D., Doel T. R. 1987a; Synthetic peptide vaccines against foot-and-mouth disease. I. Duration of the immune response and priming in guinea-pigs, rabbits and mice. Journal of Biological Standardization 15:39–51
    [Google Scholar]
  30. Murdin A. D., Doel T. R. 1987b; Synthetic peptide vaccines against foot-and-mouth disease. II. Comparison of the response of guinea-pigs, rabbits and mice to various formulations. Journal of Biological Standardization 15:53–65
    [Google Scholar]
  31. Pay T. W. F., Hingley P. J. 1987; Correlation of 140S antigen dose with the serum neutralising antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 5:60–64
    [Google Scholar]
  32. Randrup A. 1954; On the stability of bovine foot-and-mouth disease virus dependent on pH. Investigations on the complement fixing and the immunizing antigen as well as on the infective agent. Acta pathologica et microbiologica scandinavica 35:388–395
    [Google Scholar]
  33. Ross G., Dixon J. B., Veevers A. 1987; Variation in the lymphocyte transformation assay. Journal of Immunological Methods 98:189–193
    [Google Scholar]
  34. Rothbard J. B., Taylor W. R. 1988; A sequence pattern common to T cell epitopes. EMBO Journal 1:93–100
    [Google Scholar]
  35. Rowlands D. J., Sangar D. V., Brown F. 1972; Stabilising the immunising antigen of FMDV by fixation with formaldehyde. Archiv für die gesamte Virusforschung 39:274–283
    [Google Scholar]
  36. Sangar D. V., Clark R. P. 1986; An electroblotting technique for assessing the integrity of the major immunogenic protein in foot-and- mouth disease virus vaccines. Journal of Virological Methods 14:8595
    [Google Scholar]
  37. Strohmaier K., Franze R., Adam K.-H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
  38. Vasquez C., Denoya C. D., La Torre J. L., Palma E. L. 1979; Structure of foot-and-mouth disease virus capsid. Virology 97:195–200
    [Google Scholar]
  39. Wardley R. C., Chapman W. G., Garland A. J. M. 1979; A blastogenic test for foot-and-mouth disease. Journal of Hygiene 83:507–512
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-71-2-309
Loading
/content/journal/jgv/10.1099/0022-1317-71-2-309
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error